<code id='BEA12CB381'></code><style id='BEA12CB381'></style>
    • <acronym id='BEA12CB381'></acronym>
      <center id='BEA12CB381'><center id='BEA12CB381'><tfoot id='BEA12CB381'></tfoot></center><abbr id='BEA12CB381'><dir id='BEA12CB381'><tfoot id='BEA12CB381'></tfoot><noframes id='BEA12CB381'>

    • <optgroup id='BEA12CB381'><strike id='BEA12CB381'><sup id='BEA12CB381'></sup></strike><code id='BEA12CB381'></code></optgroup>
        1. <b id='BEA12CB381'><label id='BEA12CB381'><select id='BEA12CB381'><dt id='BEA12CB381'><span id='BEA12CB381'></span></dt></select></label></b><u id='BEA12CB381'></u>
          <i id='BEA12CB381'><strike id='BEA12CB381'><tt id='BEA12CB381'><pre id='BEA12CB381'></pre></tt></strike></i>

          Home / comprehensive / entertainment

          entertainment


          entertainment

          author:hotspot    Page View:58
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In